Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptive Biotechnologies Corp

10.75
+0.09000.84%
Post-market: 10.750.00000.00%19:09 EDT
Volume:1.39M
Turnover:14.89M
Market Cap:1.63B
PE:-11.21
High:10.85
Open:10.73
Low:10.54
Close:10.66
Loading ...

Recent 4.8% pullback isn't enough to hurt long-term Adaptive Biotechnologies (NASDAQ:ADPT) shareholders, they're still up 151% over 1 year

Simply Wall St.
·
24 Jul

Adaptive Biotechnologies Partners with Flatiron Health to Integrate clonoSEQ MRD Testing into OncoEMR Platform

Reuters
·
01 Jul

Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target

MT Newswires Live
·
18 Jun

Adaptive Biotechnologies Corporation Concluded Annual Shareholders Meeting

Reuters
·
13 Jun

Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA), Soleno Therapeutics (SLNO) and Adaptive Biotechnologies (ADPT)

TIPRANKS
·
12 Jun

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Zacks
·
29 May

Adaptive Biotechnologies to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Reuters
·
29 May

CFO Kyle Piskel Reports Disposal of Common Shares in Adaptive Biotechnologies Corporation

Reuters
·
20 May

Adaptive Biotechnologies Is Maintained at Overweight by Piper Sandler

Dow Jones
·
07 May

Sector Update: Health Care Stocks Higher Friday Afternoon

MT Newswires Live
·
03 May

Adaptive Biotechnologies Is Maintained at Buy by Goldman Sachs

Dow Jones
·
03 May

Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises

MT Newswires Live
·
03 May

BUZZ-Adaptive Biotechnologies rises after quarterly sales beat

Reuters
·
03 May

Stock Track | Adaptive Biotechnologies Soars 32.01% on Strong Q1 Results and Raised Guidance

Stock Track
·
02 May

Q1 2025 Adaptive Biotechnologies Corp Earnings Call

Thomson Reuters StreetEvents
·
02 May

Stock Track | Adaptive Biotechnologies Soars 11.41% Pre-market on Strong Q1 Results and Raised Guidance

Stock Track
·
02 May

Stock Track | Adaptive Biotechnologies Soars 11.41% Pre-Market on Strong Q1 Earnings Beat and Raised Guidance

Stock Track
·
02 May

BTIG Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)

TIPRANKS
·
02 May

Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Adaptive Biotechnologies (ADPT)

TIPRANKS
·
02 May

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...

GuruFocus.com
·
02 May